• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
LTP
Click for more information
0.00% 27.0¢

LTR PHARMA LIMITED - Corporate Spotlight

Market Cap $19.00M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare

LTR Pharma Limited is an Australia-based clinical-stage biopharmaceutical company. The... LTR Pharma Limited is an Australia-based clinical-stage biopharmaceutical company. The Company is focused on holistically improving men’s health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction (ED). Its lead product SPONTAN is set apart from existing ED therapies by its mechanism of action-intranasal delivery technology of a PDE5 inhibitor. The nasal cavity is a highly vascular part of the body supporting even and rapid absorption of the drug, empowering it to work in 10 minutes or less. SPONTAN (SDS-089) is a novel intranasal drug (PDE5) delivery platform for Erectile Dysfunction. More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

No Corporate Spotlight currently available.

(20min delay)
Last
27.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $19.00M
Open High Low Value Volume
27.0¢ 27.0¢ 25.0¢ $18.62K 70.88K

Buyers (Bids)

No. Vol. Price($)
3 8753 25.0¢
 

Sellers (Offers)

Price($) Vol. No.
27.5¢ 5730 1
View Market Depth
Last trade - 15.10pm 09/05/2024 (20 minute delay) ?
Last
27.0¢ 		  Change
0.000 ( 1.82 %)
Open High Low Volume
25.5¢ 27.0¢ 25.5¢ 20636
Last updated 15.04pm 09/05/2024 ?
LTP (ASX) Chart

Top Stories

Prominence impresses the market with uranium grading 5,269ppm in Kazakhstan

Prominence Energy has seen shares rise 33% on news of uranium grading up to 5,269ppm from early sampling work in Kazakhstan.
Raiden opens door to private Mallina in win-win Arrow Gold divestment Raiden Resources has announced its execution of a farm-in deal on-site Raiden's non-core asset, the Arrow gold project.
Recce breathes better on positive lung infection drug pilot test results Recce Pharmaceuticals Ltd has revealed positive results from its pilot test on synthetic drug Recce 327, which aims to treat lung infections.
UNITH's digital humans expand into Amazon; Facebook AI-powered 'Digital Human' chatbot developer UNITH has announced its in-house tech can now harmonise with that used by Facebook and Amazon.
CBA profits fall 3% in March quarter but funding portfolio is flourishing Commonwealth Bank has reported a 3 percent fall in profits for the March quarter of 2024, compared to the previous quarter.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.